{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:13:05Z","timestamp":1761534785747,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2777,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fund for Scientific Research"},{"name":"Bayer and Norbert Heimburger Chair"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1111\/jth.12891","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T02:25:05Z","timestamp":1426040705000},"page":"755-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pituitary adenylate cyclase\u2010activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-8377","authenticated-orcid":false,"given":"B.","family":"Eneman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Freson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"van hoyweghen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Collard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vande Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"van Geet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12891_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue\u2010hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"Miyata","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.12891_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase\u2010activating polypeptide and its receptors: 20\u00a0years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol Rev"},{"issue":"Pt 2","key":"10.1111\/jth.12891_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj3410271","article-title":"Identification of pituitary adenylate cyclase\u2010activating polypeptide1\u201338\u2010binding factor in human plasma, as ceruloplasmin","volume":"341","author":"Tams","year":"1999","journal-title":"Biochem J"},{"key":"10.1111\/jth.12891_bb0025","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1073\/pnas.90.13.6345","article-title":"Molecular cloning and functional expression of the pituitary adenylate cyclase\u2010activating polypeptide type\u00a0I receptor","volume":"90","author":"Pisegna","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12891_bb0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/bbrc.1993.1658","article-title":"Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor","volume":"193","author":"Sreedharan","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.12891_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-5793(93)81668-P","article-title":"The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide","volume":"334","author":"Lutz","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1111\/jth.12891_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0090-6980(99)00039-8","article-title":"Effects of pituitary adenylate cyclase\u2010activating polypeptide on the cyclooxygenase pathway of rat platelets and on platelet aggregation","volume":"58","author":"Kis","year":"1999","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/jth.12891_bb0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI200419252","article-title":"The pituitary adenylate cyclase\u2010activating polypeptide is a physiological inhibitor of platelet activation","volume":"113","author":"Freson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12891_bb0050","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2007-06-098558","article-title":"PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications","volume":"111","author":"Freson","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12891_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2141.2010.08327.x","article-title":"Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis","volume":"151","author":"Peeters","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12891_bb0060","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.007625","article-title":"Pituitary adenylate cyclase\u2010activating polypeptide (PACAP) impairs the regulation of apoptosis in megakaryocytes by activating NF\u2010kappaB: a proteomic study","volume":"11","author":"Di Michele","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/jth.12891_bb0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","article-title":"The nephrotic syndrome","volume":"338","author":"Orth","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12891_bb0070","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1542\/peds.2006-2164","article-title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)","volume":"119","author":"Hinkes","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/jth.12891_bb0075","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/ndt\/gfm759","article-title":"Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS)","volume":"23","author":"Gbadegesin","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.12891_bb0080","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"Maas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.12891_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12891_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.12891_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome\u2010associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jth.12891_bb0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.1971.00310180037003","article-title":"Nephrotic syndrome. A hypercoagulable state","volume":"127","author":"Kendall","year":"1971","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12891_bb0105","first-page":"399","article-title":"Changes in blood coagulation and fibrinolysis in the nephrotic syndrome","volume":"43","author":"Thomson","year":"1974","journal-title":"Q J Med"},{"issue":"Suppl. 1","key":"10.1111\/jth.12891_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000168196","article-title":"Coagulation factors in nephrotic syndrome","volume":"10","author":"Kanfer","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1111\/jth.12891_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0033-1343887","article-title":"Thrombosis in nephrotic syndrome","volume":"39","author":"Barbano","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12891_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-0038-1653432","article-title":"Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome","volume":"46","author":"Boneu","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12891_bb0125","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/archinte.1984.00350210124021","article-title":"Acquired deficiency and urinary excretion of antithrombin\u00a0III in nephrotic syndrome","volume":"144","author":"Vaziri","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12891_bb0130","first-page":"218","article-title":"Plasma concentrations of the natural anticoagulants protein\u00a0C and protein\u00a0S in patients with proteinuria","volume":"106","author":"Cosio","year":"1985","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.12891_bb0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF01955944","article-title":"Haemostatic measurements in childhood nephrotic syndrome","volume":"150","author":"Elidrissy","year":"1991","journal-title":"Eur J Pediatr"},{"key":"10.1111\/jth.12891_bb0140","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/pgmj.70.830.905","article-title":"Arterial thrombosis in the nephrotic syndrome","volume":"70","author":"Fahal","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1111\/jth.12891_bb0145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000186178","article-title":"Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome","volume":"56","author":"Ueda","year":"1990","journal-title":"Nephron"},{"key":"10.1111\/jth.12891_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000188254","article-title":"Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy","volume":"68","author":"Andre","year":"1994","journal-title":"Nephron"},{"key":"10.1111\/jth.12891_bb0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00467-004-1620-z","article-title":"Platelet\u2010derived growth factor and platelet profiles in childhood nephrotic syndrome","volume":"20","author":"Wasilewska","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/jth.12891_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood.V52.5.969.969","article-title":"Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome","volume":"52","author":"Yoshida","year":"1978","journal-title":"Blood"},{"key":"10.1111\/jth.12891_bb0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0049-3848(79)90082-3","article-title":"Platelet hyperaggregability and the nephrotic syndrome","volume":"16","author":"Remuzzi","year":"1979","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12891_bb0170","first-page":"182","article-title":"Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration","volume":"27","author":"Bennett","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1111\/jth.12891_bb0175","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ki.1989.310","article-title":"Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome","volume":"36","author":"Machleidt","year":"1989","journal-title":"Kidney Int"},{"key":"10.1111\/jth.12891_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1172\/JCI116947","article-title":"Thrombus formation and platelet\u2013vessel wall interaction in the nephrotic syndrome under flow conditions","volume":"93","author":"Zwaginga","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12891_bb0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000064282","article-title":"Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests","volume":"91","author":"Sirolli","year":"2002","journal-title":"Nephron"},{"key":"10.1111\/jth.12891_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2013.169","article-title":"The podocyte slit diaphragm \u2013 from a thin grey line to a complex signalling hub","volume":"9","author":"Grahammer","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/jth.12891_bb0195","doi-asserted-by":"crossref","first-page":"1251033","DOI":"10.1126\/science.1251033","article-title":"Transcriptional diversity during lineage commitment of human blood progenitors","volume":"345","author":"Chen","year":"2014","journal-title":"Science"},{"key":"10.1111\/jth.12891_bb0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH11-09-0673","article-title":"Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome","volume":"107","author":"Gao","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12891_bb0205","first-page":"1647","article-title":"Platelet functions and coagulation changes in Indian children with nephrotic syndrome","volume":"7","author":"Mittal","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1111\/jth.12891_bb0210","first-page":"651","article-title":"Enhanced platelet function in glomerular renal disease","volume":"81","author":"Bang","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.12891_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10245330600940048","article-title":"Thromboembolism in childhood nephrotic syndrome: a rare but serious complication","volume":"12","author":"Zaffanello","year":"2007","journal-title":"Hematology"},{"key":"10.1111\/jth.12891_bb0220","first-page":"507","article-title":"Thrombocytosis in children","volume":"63","author":"Chiarello","year":"2011","journal-title":"Minerva Pediatr"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12891","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622089863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622089863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12891\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:10:00Z","timestamp":1761534600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622089863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1538783622089863"],"URL":"https:\/\/doi.org\/10.1111\/jth.12891","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary adenylate cyclase\u2010activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}